Resultados de la búsqueda

From 4 to 7 November, GOGOA  took an active part in A+A 2025 , the world’s leading international trade fair for workplace safety, occupational health and risk prevention, held in Düsseldorf (Germany). This event is widely regarded as the global benchmark for organisations and professionals committed to enhancing wellbeing and safety at work through technological innovation. In this edition, GOGOA  engaged closely within the EXOPARK , a dedicated demonstration space focused exclusively on exoskeletons and physical assistance technologies. This environment enables visitors to experience, compare and assess  how such solutions can effectively reduce muscular fatigue , prevent musculoskeletal injuries , and improve performance in physically demanding tasks . A Setting for Connection, Learning and Strategic Partnership Participation in EXOPARK enabled GOGOA  to: • Observe the most current trends in industrial exoskeletons and supportive wearable technologies. • Establish new strategic partnerships  with companies, distributors, and international research centres. • Exchange real-world implementation experiences across sectors such as automotive, manufacturing, logistics and advanced maintenance. • Promote an implementation approach grounded in data, ergonomics, and continuous on-site support . Commitment to Health and Workplace Wellbeing GOGOA  is a European reference in applied bioengineering, specialising in the design and development of exoskeletons for industrial, clinical and rehabilitation applications. Our purpose is to enhance physical capability , safeguard health , and foster working environments that are safer, more sustainable, and more efficient . We collaborate closely with companies to: • Analyse tasks and musculoskeletal risk factors • Identify the most suitable assistance solution for each use case • Train and support users and prevention teams • Measure impact and ensure stable, long-term adoption Looking Ahead Following A+A 2025, GOGOA  is entering a new phase of pilot projects, international collaborations and case-study validation . Our objective remains unchanged: to create technology that is useful, accessible, and genuinely centred on people . Interested in exploring how exoskeletons could improve ergonomics in your organisation? We are ready to help you evaluate the potential and guide the process. Contact us and let’s move forward together. Contact (+34) 666 325 361 info@gogoa.eu c / Arzubia 10B, 7 bajo 48220 Abadiño (Bizkaia) SPAIN – EUROPE

In the furrows and in the warehouses — where the working day is measured in repeated gestures and in arms that sustain the harvest — a deliberate, practical response is being trialled: ExoKOOP , a pilot project that deploys and evaluates passive exoskeletons across Basque cooperatives to mitigate musculoskeletal fatigue and enhance ergonomics without compromising productivity. This is no abstract experiment: it is an intervention in everyday toil, founded upon people, empirical evidence and practicable recommendations. Executive summary — why this matters ExoKOOP arises from a fundamental premise: to protect the health of those who labour the land . Its proposition is both lucid and measurable: introduce passive exoskeletons — devices without motors, based upon variable-deformation elastomers that emulate muscle-like behaviour  — into genuine field and logistics tasks; quantify their effect upon posture, fatigue and performance; and distil that evidence into repeatable protocols for cooperatives. It is technology in the service of work: discreet, functional and humane. What precisely is ExoKOOP? ExoKOOP is an applied pilot with a clear objective: to reduce the risks posed by repetitive movement, sustained postures and manual handling. The methodology is straightforward and rigorous: compare, in authentic working conditions, cohorts operating with and without exoskeletons; record entire shifts; and gather both objective metrics and first-hand testimony from the workforce. The aim is not rhetorical demonstration but quantification and actionable outcomes. Where and which tasks are being tested Trials take place within cooperatives that exemplify the sector’s operational variety: Field — harvesting and transport:  repeated cycles of picking, bending, lifting and moving boxes in seasonal crops (currently tomato and guindilla). Logistics — warehousing:  loading and unloading, sack handling and continuous manual throughput. The approach is realistic and whole-shift focused: we observe work in the round, not in isolated snapshots. Who participates — the institutional and operational partnership KONFEKOOP (Confederation of Cooperatives of Euskadi):  institutional coordinator and conduit to the cooperatives; prevention and operational liaison led by Sergio Achicallende . Barrenetxe S. Coop.:  field trial host for agricultural operations. Tiendas San Isidro de Mungia S. Coop.:  logistics and warehouse validation. GOGOA BIOENGINEERING:  designer and supplier of the passive exoskeletons, provider of implantation methodology and of MonitorEX , the instrumentation platform that renders subjective experience into actionable data. This alliance combines practical expertise with technical responsibility so that the intervention is at once respectful of operations and robust in its methodology. Technology: passive exoskeletons — silent, purposeful support There are no motors, no batteries — assistance is derived from intelligent materiality : Variable-deformation elastomers  that store and return energy in a controlled fashion. The devices accompany movement rather than dictate it, alleviating load without impeding natural motion. Models under evaluation: ExoSoft  (lumbar support), ExoArms  (upper-limb assistance), ExoShoulder  (support for overhead work) and ExoHead  (cervical and scapular relief). Benefits include minimal maintenance, straightforward fitting, compatibility with personal protective equipment and favourable acceptance among workers. Here, innovation is materially modest and functionally profound: simplicity serving the human body. MonitorEX: measuring to decide, not to persuade Where anecdote ends and policy begins, measurement must take the lead. MonitorEX  captures posture and fatigue markers across full shifts, enabling: Quantitative comparison between cohorts with and without devices. Correlation of objective indicators (posture, task time, breaks) with subjective reports (perceived exertion, comfort). Formulation of precise guidance: which device, which setting, and which training regime deliver benefit. The principal data collection commenced in late October, with a notable recording session on 28 October , followed by successive iterations of adjustment and worker feedback. What has been achieved so far — trials, evidence and voices Deployment of multiple passive models across participating cooperatives. Continuous recording during authentic tasks based upon a comparative experimental design. Systematic feedback from workers on perceived relief, fit and usability. Preparation of dissemination materials: newsletters, a best-practice memo and professionally produced video content. Public communication: participation in an episode of Onda Vasca  to present the project and foreground the perspectives of those in the field and the technical team.🎧 Listen here: https://www.ondavasca.com/la-innovacion-ha-entrado-en-el-campo-vasco-con-exoesqueletos-para-proteger-la-salud-de-los-trabajadores-agrarios/ Preliminary findings and a cautious interpretation We do not trade in grand claims. Early indications are encouraging — there is perceived reduction in fatigue in specific tasks and positive reception where fit and instruction are meticulous — yet scaling must await robust statistical analysis and the establishment of training protocols. ExoKOOP seeks operational conclusions, not premature headlines. Professional films and a practical memorandum To make the learning transferable, we are producing a series of professional films that will document: Field demonstrations. Testimonies from workers and technicians. Adjustment procedures and operational recommendations. These films, together with a formal best-practice memorandum, will constitute the practical handbook for those intent on replication. Next steps — a practical roadmap Conclude data collection and complete comparative analyses. Publish the best-practice memorandum with technical recommendations and training protocols. Release the professional video series and convene demonstration days across the Basque provinces. Prepare tailored replication proposals for other cooperatives and logistics centres. For cooperative managers — the proposition in brief ExoKOOP offers a replicable procedure: diagnose, implement, instrument with MonitorEX, measure and deliver a concise, practicable report with clear decisions. If you oversee operations with significant physical demands and wish to evaluate an intervention with rigour, GOGOA BIOENGINEERING, in partnership with KONFEKOOP, will design and execute the pilot so that investment in health returns operational and human dividends.

📹 Full video of the conference available at the end of this article. 21 October 2025. Hospital Quirónsalud Bizkaia, Erandio. At six o’clock in the evening, the auditorium was already full. Healthcare professionals, physiotherapists, engineers, patients and families gathered with a shared sense of hope: to witness how technology can change lives. The First Conference on Health and Robotic Neurorehabilitation, organised by Hospital Quirónsalud Bizkaia and Gogoa Mobility Robots, marked a turning point. The event commemorated the first anniversary of the Robotic Neurorehabilitation Unit at Hospital Quirónsalud Bizkaia , as well as the tenth anniversary of GOGOA  — a decade in which the Basque company has led innovation in health-focused robotics, developing solutions that are already transforming motor and cognitive rehabilitation. An alliance that unites science, technology and humanity The conference was formally opened by Carlos F. Isoird, CEO of GOGOA , who shared a clear and inspiring vision: “The rehabilitation of the future will be technological, personalised and profoundly human.” That statement perfectly encapsulates the spirit of the pioneering collaboration between GOGOA and Hospital Quirónsalud Bizkaia, which has given rise to a unique model of care. Within the Robotic Neurorehabilitation Unit, technology is placed at the service of each individual, adapting to their diagnosis, abilities and recovery goals in a hospital environment. Each treatment is designed in a personalised manner, combining the clinical expertise of the physiotherapy team with the use of advanced robotic devices developed by GOGOA: lower-limb and upper-limb exoskeletons, stimulation systems and virtual reality, among others. Humanising technology During her address, Sara García , neurological physiotherapist and head of the Unit, explained that their daily work begins with understanding each patient’s needs before introducing any technology: “The first step is to know the person — to understand where they are now and where they can go. Technology helps refine the therapy, but the key remains human.” The event also gave a voice to Alberto Yanes , a patient with cervical myelopathy, who recounted his progress since beginning treatment: “I arrived with balance problems and, after just a few sessions, I could already feel a great improvement.” His sincere and humble testimony moved the audience and gave a human face to what innovation truly means: walking again, regaining independence — in short, reclaiming life. The Exo Show: innovation in motion The most eagerly awaited moment of the evening came with the Exo Show  — a live demonstration of the technology developed by GOGOA. Attendees witnessed HANK , the lower-limb robotic exoskeleton designed for gait rehabilitation, in full operation, alongside other solutions currently used within the unit. Isoird explained that the development of these devices is based on a fundamental principle: absolute personalisation . Each system adapts to the patient, not the other way round. Therapists can adjust parameters in real time, ensuring natural and safe movement throughout the rehabilitation process. The scene perfectly encapsulated the central message of the event: technology does not replace the professional — it amplifies their ability to help. Science and shared experience The conference concluded with a round table moderated by Alejandra de Miota , featuring Carlos F. Isoird , Guillermo Asín  (GOGOA’s Director of R&D), Sara García , Dr. Alejandro Durán  (Head of the Neurology Department at Hospital Quirónsalud Bizkaia), and Alberto Yanes , a patient of the unit. Dr. Durán emphasised the essential role of robotics in the treatment of neurological conditions, both acute and chronic: “Any condition that causes neurological deficit can benefit from robotic neurorehabilitation. It is never too late to begin.” He also stressed: “Technology helps us prevent the loss or paralysis of vital functions, such as eating or walking. Rehabilitation is essential to stop patients from deteriorating or, at the very least, to slow the decline in functional mobility.” For his part, Guillermo Asín  highlighted the value of uniting engineering and medicine: “Useful robotics is not the most spectacular, but the kind that adapts and measures therapy according to the patient’s progress.” A future that is already present The First Conference on Health and Robotic Neurorehabilitation was far more than a record-breaking event. It confirmed that the partnership between GOGOA and Hospital Quirónsalud Bizkaia is setting a new standard in neurological rehabilitation — a model founded on evidence, personalisation and the union of science and humanity. In a world where neurological challenges increase every year, this alliance demonstrates that clinical robotics is now an essential tool , capable of multiplying opportunities for recovery and restoring hope to thousands of people. The event concluded with heartfelt applause and a shared certainty: innovation does not only move muscles — it moves lives. From GOGOA, we extend our deepest gratitude to all speakers, healthcare professionals, patients, families and attendees who made this historic day possible. Your dedication and enthusiasm inspire us to continue building, together with Hospital Quirónsalud Bizkaia, the future of robotic neurorehabilitation. 📹 Full video of the event GOGOA Hospital Quirónsalud Bizkaia neurorrehabilitación robótica jornada GOGOA Hospital Quirónsalud Bizkaia neurorrehabilitación robótica jornada

Published: 20 October 2025 The European project REVITAL – Socioeconomic revitalisation of sparsely populated areas through clinical telecare  has taken a decisive step forward in Portugal. On 8 October , the Escola Superior de Saúde Dr. Lopes Dias (ESALD) , part of the Instituto Politécnico de Castelo Branco (IPCB) , hosted the first clinical training and testing session with the HANK and BELK exoskeletons , developed by Gogoa Mobility Robots . This initiative demonstrates how advanced robotic rehabilitation, virtual reality and tele-rehabilitation technologies  can be deployed beyond major hospitals and brought directly to rural populations with limited access to specialised care . REVITAL: Innovation and Healthcare at the Service of the Community REVITAL  is a cross-border European initiative financed by the Interreg VI-B Sudoe 2021–2027 Programme , with a total budget of €2,131,109 , of which €1,598,331.75 is co-funded by the European Regional Development Fund (FEDER) . Its mission is to: Improve access to specialised healthcare and neurorehabilitation  in low-density regions of Spain, Portugal and France. Combat rural depopulation  by creating new health, technology and rehabilitation services. Promote social innovation and digital health , empowering local professionals and institutions. The project is coordinated by the SIVI Cluster (Innovative Solutions for Independent Living)  and includes partners such as AEBB , ESALD/IPCB , Gogoa Mobility Robots , the University of Deusto , ESTIA (France)  and various healthcare organisations across the Sudoe region. Clinical Training with HANK and BELK at ESALD During this first session, physiotherapists and lecturers from ESALD received technical and clinical training in two key robotic rehabilitation systems: HANK  – a lower-limb exoskeleton for gait rehabilitation  in individuals with stroke, spinal cord injury or neurodegenerative conditions. It enables precise, repetitive and measurable training sessions . BELK  – a motorised knee exoskeleton  designed to support knee extension, gait stability and post-injury recovery , in both unilateral and bilateral configurations. Training included: Patient set-up and calibration Safety and inclusion criteria Adjustment of assistance levels Recording of gait parameters (cadence, step length, symmetry, fatigue, perceived exertion) Data logging for clinical monitoring and future research Next Steps: Clinical Pilots in Castelo Branco and São Miguel d’Acha In the coming weeks, real patient trials will begin  in two pilot sites: ESALD’s Pedagogical Clinic (Castelo Branco) São Miguel d’Acha , a rural community participating in the REVITAL programme The clinical pilots aim to evaluate: Improvements in gait, balance and activities of daily living Acceptance of robotic rehabilitation by patients and healthcare professionals Effectiveness of hybrid care models combining in-person therapy and tele-rehabilitation Reduction in travel for rural populations requiring long-term rehabilitation Gogoa Mobility Robots: Democratizing Robotic Rehabilitation As a technological partner, Gogoa Mobility Robots  contributes: Advanced clinical exoskeletons : HANK (gait), BELK (knee) and HELK (lumbar support) Specialised training for physiotherapists and clinicians Expertise in clinical protocols, biomechanical data analysis and performance indicators Support to scale and replicate the model across other rural regions in the Sudoe area Impact of REVITAL ✔ Improved access to specialised rehabilitation  in rural areas ✔ Higher therapy intensity and measurable clinical outcomes  through robotic assistance ✔ New professional opportunities in digital health and physiotherapy 4.0 ✔ Transferable, scalable model  for other rural communities in Spain, Portugal and France Conclusion REVITAL illustrates how technology, healthcare and territorial cohesion  can work together to reduce inequalities in access to rehabilitation. Thanks to initiatives like this, robotic neurorehabilitation is no longer limited to large urban hospitals , but is reaching local communities, elderly populations and patients with mobility impairments . If your clinic, hospital or university is interested in implementing robotic rehabilitation or collaborating in European innovation projects, contact Gogoa Mobility Robots.

Chronic Pain, HSP & PLS — How GOGOA Brings Hope Today, 17 October 2025 , we mark two deeply meaningful observances: the World Day Against Pain  and the first-ever World Day of Hereditary Spastic Paraparesis (HSP)  and Primary Lateral Sclerosis (PLS) . Two distinct commemorations, yet united by a shared purpose — the pursuit of quality of life  for those living with chronic pain or neurological conditions that restrict movement. This year, patient associations around the world  — including AEPEF  in Spain — have joined forces to raise awareness, call for stronger research investment, and promote access to advanced therapeutic solutions . Understanding HSP and PLS Hereditary Spastic Paraparesis (HSP)  and Primary Lateral Sclerosis (PLS)  are rare neurodegenerative disorders  that primarily affect motor function . 🧠 HSP  (Hereditary Spastic Paraparesis) comprises a group of genetic conditions that cause progressive weakness and stiffness in the legs , often making walking and balance increasingly difficult. In more complex forms, other systems such as vision, coordination, or sensation may also be involved. 🧬 PLS  (Primary Lateral Sclerosis) is a slowly progressive upper motor neuron disease , leading to spasticity, rigidity, and gait difficulties , and in later stages, may affect speech or swallowing . Although its progression tends to be slower than that of other motor neuron diseases, its impact on everyday life can be profound  — walking, standing, or maintaining balance become daily challenges. These disorders not only affect the body — they test one’s independence, confidence, and emotional resilience , both for those who live with the disease and their loved ones. World Day Against Pain: Relief is a Human Right The World Day Against Pain , led by the IASP  and endorsed by the WHO , reminds us that relieving pain is a fundamental human right . Chronic pain affects more than 20% of the global population , and within many neurological conditions, it remains one of the most invisible and misunderstood symptoms . This day calls for breaking stigma, driving research, and ensuring that all people have access to effective and safe pain management therapies . How GOGOA Helps At GOGOA , we believe that technology must serve people .Our mission is to develop neurorehabilitation and assistive technologies  that blend science, engineering, and empathy  to enhance mobility, independence, and quality of life. Working alongside clinicians, therapists, researchers, and patients , we deliver innovative therapies that integrate neuromodulation, robotics, and personalised clinical programmes . 1️⃣ Non-invasive Neuromodulation with ALPERK ALPERK  is our non-invasive vagus nerve stimulation (VNS)  device, designed to boost neuroplasticity  — the brain’s ability to reorganise and form new connections — and to support both motor and cognitive recovery . Clinical studies have demonstrated that pairing vagus nerve stimulation with therapeutic exercise  can significantly improve motor outcomes after stroke.Our goal with ALPERK is to bring these benefits into non-invasive, safe, and accessible clinical settings . The vagus nerve also plays a crucial role in pain modulation and inflammatory response regulation , making neuromodulation an emerging ally  in managing chronic pain and spasticity . Benefits for Patients with HSP, PLS or Chronic Pain Improves muscle tone regulation  and reduces fatigue. Enhances motor therapy outcomes  when paired with functional exercise. Promotes better pain control  by influencing the autonomic nervous system. ALPERK is a non-invasive  medical technology, always applied under clinical supervision , and acts as a complementary therapy  alongside standard medical and rehabilitation treatments. 2️⃣ Robotic Therapy and Exoskeletons Robotic-assisted therapy  enables patients to relearn movement  in a safe, intensive, and motivating way.At GOGOA, we design and manufacture rehabilitation and assistive exoskeletons  that help individuals with neurological disorders walk, strengthen muscles, and maintain proper posture  — even when their nervous system can no longer fully coordinate movement. These therapies: Provide repetitive and precise practice , activating the neural circuits responsible for movement. Can help reduce spasticity  and improve coordination. Increase motivation and engagement , allowing patients to witness measurable progress. 3️⃣ Personalised Programmes: Technology That Adapts to You No two people are alike. Our programmes are custom-designed  to suit each individual’s diagnosis, abilities, environment, and goals. A treatment plan may include: Comprehensive evaluation  (gait, strength, pain, fatigue, balance). A combined plan  of ALPERK neuromodulation , robotic or conventional physical therapy , and therapeutic education  for self-care and pain management. Ongoing monitoring  and adjustment based on measurable outcomes. Who We Work With 👩‍🦽 Patients and Families: We help people regain mobility, confidence, and independence  through safe, comfortable, and motivating therapy sessions. 👩‍⚕️ Healthcare Professionals: We provide training, clinical support, and data analysis  to integrate neuromodulation and robotics into rehabilitation programmes. 🏥 Hospitals and Clinics: We implement certified protocols , ensure data traceability and safety , and offer continuous maintenance and technical support . A Gesture that Unites The symbol of the day is the “link” gesture , a chain representing the solidarity of the global HSP and PLS community.Today , we invite you to share your photo making the link gesture  on social media to show that no one stands alone .Tag @AEPEF  and join the international movement for visibility and research. At GOGOA, We Believe in Active Hope The future of neurorehabilitation depends on the collaboration between science, technology, and humanity .Every innovation we develop shares a single goal: that more people can move, live, and enjoy life — free from pain . 📩 Whether you are a patient, healthcare professional, or rehabilitation centre , contact us to learn how to integrate ALPERK  and our rehabilitation exoskeletons  into your therapeutic programme:👉 www.gogoa.eu Suggested hashtags: #WorldDayAgainstPain #HereditarySpasticParaparesis #PrimaryLateralSclerosis #ChronicPain #Neurorehabilitation #ALPERK #Exoskeletons #MedicalInnovation #GOGOA #NeurologicalHealth #TechnologyThatCares

PREVENZIONA x GOGOA AT WORKSAFE BARCELONA 2025 A few weeks ago, GOGOA, together with our partner PrevenZiona , took part in WorkSafe Barcelona 2025 , the benchmark event for prevention, protection, and occupational health . The response was outstanding: highly technical conversations and a clear focus on real-world deployment at scale. We are grateful to all those who visited us and shared their operational challenges. Our value proposition Industrial prevention exoskeletons (GOGOA / Cyber Human Systems) Ergonomic assistance for overhead work, light-to-moderate load handling and sustained postures (shoulders, neck, lumbar region). Objective: reduction of MSD risk  and fatigue  in repetitive or static tasks, without compromising productivity. Integrated PPE solutions (PrevenZiona) Selection, fit, and implementation plans grounded in risk assessment. Innovations in hand, head and respiratory protection, fall from height, and chemical protection, with sector-specific focus. Methodology & ongoing support Integration with ergonomic assessments, pre–post  protocols, performance indicators, and a roadmap for scaling  beyond pilot. Market trends observed From pilot to rollout Growing demand for clear criteria to select use-cases and to govern change across sites. Decisions grounded in data Strong interest in objective metrics (time in awkward postures, perceived exertion, usage rates, absenteeism). Prevention as competitive advantage Ergonomics programmes geared towards sustainable operations and employer branding . Our methodological approach: from assessment to outcome Job analysis: In-situ observation; task characterisation (frequency/duration), loads, working heights and critical postures. Controlled pilot (typically 4–8 weeks): Training, individual fitting, safe-use checklists, and pre–post  measurement: Ergonomics: % reduction in time with shoulder elevation >60°, sustained lumbar flexion. People: perceived exertion (Borg), reported discomfort, adoption rate. Operations: output stability and quality integrity. Scale-up and standardisation: Procedures, eligibility criteria by workstation, maintenance and hygiene, and a dashboard with quarterly reviews . Continuous improvement: Technical and ergonomic support, micro-adjustments to process, PPE compatibility and task rotation. Sectors and use-cases generating the greatest interest Automotive & Tier-1 : overhead fastening and assembly, inspection above shoulder height. Logistics : picking at lower/mid levels with repetitive flexion. Food & beverage : replenishment and sustained-rhythm operations. Maintenance & facility services : cabling, luminaires, ducting and overhead supports. Key questions and our position Do exoskeletons replace other control measures? No. Exoskeletons are a complement  within the hierarchy of controls. Engineering and organisational measures are prioritised; where these are not feasible or sufficient, exoskeletons provide effective mitigation  of exertion. How do you ensure workforce adoption? Early engagement with teams, on-shift trials, individual fitting, concise training, PPE compatibility, and follow-up. The felt benefit  is decisive for adherence. What about maintenance and hygiene? Low maintenance: routine cleaning, visual checks, replacement of wear parts, and protocols tailored to sector requirements. The GOGOA + PrevenZiona advantage Rigorous use-case selection : we deploy when it truly adds value; if not, we advise against it with clear technical criteria. Reduced learning curve : fitting, training, and on-site support to accelerate adoption. Measured impact : ergonomic, health, and operational KPIs with traceability for decision-making. Programme sustainability : operational standardisation and continuous improvement aligned with business objectives. Thank you To everyone who visited our stand, thank you  for your time and for the quality of the conversations. Your emphasis on evidence, safety and performance reflects a maturing market and raises the bar for prevention in Spain. If you were unable to attend, you may review our capabilities and request a workplace assessment: → Discover how we can help:   www.cyberhs.eu About GOGOA / Cyber Human Systems GOGOA is a leading biomedical engineering company specialising in the development and deployment of industrial and rehabilitation exoskeletons , with a focus on safety, ergonomics and sustainable productivity . Through Cyber Human Systems , we transfer cutting-edge technology to industrial environments under robust quality and regulatory standards. About PrevenZiona PrevenZiona is a specialist partner in occupational risk prevention  and PPE , providing end-to-end services from risk assessment and solution selection to implementation and follow-up. Keywords:  industrial exoskeletons, occupational risk prevention, ergonomics, MSD, occupational health, PPE, sustainable productivity, implementation, continuous improvement. Hashtags: #WorkSafeBarcelona #PPE #OccupationalSafety #RiskPrevention #Ergonomics #Industry #WorkplaceHealth #SafetyCulture #CHS #GOGOA #PrevenZiona gogoa-prevenziona-exoesqueletos-prl-worksafe-2025 gogoa-prevenziona-exoesqueletos-prl-worksafe-2025

Dubai, October 2025. At the world’s grandest stage for technology and innovation — where artificial intelligence, biotechnology, and advanced robotics converge — one European company shines with singular brilliance.  Gogoa Mobility Robots , a pioneer of Basque bioengineering, has been  officially invited to participate in GITEX Global 2025 , the most prestigious technology and innovation event on the planet. This invitation arrives in a milestone year:  Gogoa celebrates its tenth anniversary  as a company that has transcended the limits of robotics to become a  global benchmark in biomedical engineering and life-enhancing technologies for health, prevention, and human performance . GITEX GLOBAL 2025: THE STAGE WHERE THE FUTURE TAKES SHAPE From  13 to 17 October , the  Dubai World Trade Centre  and  Dubai Harbour  will host more than  200,000 visitors  and  6,000 exhibitors  from 170 nations. GITEX Global  is far more than a technology fair; it is the meeting point where the world’s foremost innovators debate, experiment, and envision the decade ahead. From artificial intelligence and biotechnology to digital health, clean energy, cybersecurity, and smart mobility, GITEX gathers under one roof the forces that are redefining the future.And this year, among global giants,  Gogoa will stand as the new frontier of bioengineering — applying science and design to advance health, prevention, and human capability. GOGOA: A DECADE LEADING THE NEW ERA OF BIOENGINEERING What began ten years ago as a Basque start-up devoted to exoskeletons for neurorehabilitation has evolved into an international company that designs, develops, and integrates  technologies aimed at expanding both physical and cognitive capacity . At Gogoa, engineering is never an end in itself, but a  means to elevate human potential . Today, its innovation ecosystem embraces three major domains: Health and Functional Recovery:  robotic solutions, cognitive systems, and intelligent therapies that optimise motor, neurological, and mental rehabilitation. Prevention and Well-being:  biomedical technologies that analyse, strengthen, and preserve muscular and neurological function, reducing risk of injury and deterioration. Sport and Performance:  tools that enable elite athletes and professionals to enhance performance, resilience, and recovery through data, neurostimulation, and advanced feedback. “At Gogoa we don’t just help people walk again — we help the world move forward. Our purpose is to unlock human potential, from the patient who learns to trust their body once more to the athlete striving to surpass their own limits.” —  Galder Arego, Brand Strategy Director, GOGOA Mobility Robots IN DUBAI: TECHNOLOGY THAT UNITES SCIENCE AND LIFE At  GITEX Global 2025 , Gogoa will present a new paradigm in bioengineering —  systems that merge artificial intelligence, adaptive robotics, biomechanical analytics, and applied neuroscience .The goal: to design intelligent therapeutic environments and sustainable experiences of human enhancement. During the event, Gogoa will unveil: Clinical and modular exoskeletons , suitable for both rehabilitation and physical training. Integrated cognitive-motor systems , capable of measuring and enhancing brain performance during movement. Advanced biomechanical assessment platforms  for injury prevention and performance optimisation. Tailored therapeutic projects , combining data, sensors, and predictive analytics to personalise every recovery journey. “The future of healthcare will not merely cure or restore — it will anticipate, enhance, and prevent. Gogoa is building that future.” —  Carlos F. Isoird, CEO, Gogoa Mobility Robots AN INVITATION THAT CELEBRATES EUROPEAN EXCELLENCE GITEX’s invitation acknowledges not only technological innovation but also the global impact of Gogoa’s distinctive model: a company that designs technology, applies clinical science, and operates its own network of therapeutic centres —  Gogoa Clinics , where research translates directly into tangible outcomes. This complete ecosystem — from design to clinical application — has positioned Gogoa as a  leader in integrated biomedical engineering , capable of bridging academia, industry, and human experience. INTERNATIONAL GROWTH AND EXPANSION Gogoa’s participation in GITEX cements its international projection. The company already develops projects and partnerships across  Europe and the United States , while its 2025–2030 strategy targets  new markets in the Middle East, Asia, and Latin America . With sustained investment in R&D —  over 30% of annual revenue dedicated to innovation  — Gogoa is shaping a future in which bioengineering becomes a driver of economic, medical, and social progress. “From the Basque Country to the world. We aim to prove that European innovation can lead the global transformation of health and human performance.” —  Guillermo Asín, R&D Director, Gogoa Mobility Robots GOGOA AT GITEX: TO LEAD IS TO INSPIRE In Dubai, Gogoa will showcase more than technology — it will share a vision:  a bioengineering that unites science, technology, and purpose. Where others display algorithms or prototypes, Gogoa will present  a new way of understanding human potential . Because leadership is not only about innovation. Leadership is about inspiration. And at  GITEX Global 2025 , Gogoa will demonstrate that  engineering can be every bit as human as the heart that drives it. GOGOA MOBILITY ROBOTS Global leader in bioengineering for health, prevention, and human performance.

Last week, the consortium of the  VIVELAB-EXO  project undertook a pivotal phase of data collection and evaluation within the  Human-Centric Laboratory  at CTAG’s state-of-the-art facilities. This milestone underscores the shared commitment of all partners to transform industrial ergonomics and exoskeleton deployment into a measurable, safe, and widely accessible reality. What is VIVELAB-EXO? VIVELAB-EXO  is an initiative co-funded by  EIT Manufacturing , uniting the expertise of  CTAG ,  ViVeTech Nyrt. ,  GOGOA Mobility Robots , and  FAREL Plastics  (a Wirthwein Group company). Its mission is to pioneer an innovative methodology to evaluate the ergonomic benefits of exoskeletons, harnessing the power of  advanced simulation  and  human digital twins . The vision is bold yet clear: to deliver a tool that accelerates the adoption of physical assistance devices across manufacturing and beyond, providing quantifiable evidence of their ability to reduce strain, prevent musculoskeletal disorders, and enhance worker well-being. Scientific and Technical Challenges The creation of human digital twins seamlessly integrated with exoskeleton models poses a fascinating array of challenges: Multimodal data capture – encompassing kinematics, muscular forces, posture, fatigue, and workload. Coupled human–machine simulation – ensuring biomechanical models truly reflect real-world behaviours. Experimental validation with participants – calibrating digital models with empirical data. Decision-making interfaces – enabling ergonomists and industry leaders to interpret simulations with clarity and confidence. Recent Progress at CTAG In this latest campaign at CTAG: Extensive human data collection was carried out under controlled conditions simulating industrial tasks. Comparative assessments were undertaken to quantify the biomechanical differences between scenarios with and without exoskeleton assistance. These data sets are now feeding into the calibration of simulation models and digital twins. The exercise reinforced the cross-sector collaboration of the consortium, a decisive element in ensuring scientific rigour and industrial relevance. Such laboratory trials are indispensable, ensuring that digital simulations remain firmly anchored in reality, whilst providing invaluable insight into improvements required for real-world applications. Why It Matters for GOGOA As a core partner,  GOGOA  brings expertise in exoskeleton technology and industrial integration. The success of VIVELAB-EXO directly enhances our mission to set the standard in physical assistance solutions. Key benefits include: Delivering a digital decision-making tool for manufacturers to anticipate the impact of exoskeletons before large-scale adoption. Lowering barriers to acceptance by providing robust, quantitative evidence of ergonomic benefits. Cementing GOGOA’s role as a European frontrunner in industrial ergonomics and human-centred robotics. Moreover, synergies with the  SUPERHUMAN project  reinforce our trajectory towards next-generation solutions for fatigue mitigation and safe human-robot collaboration. The Road Ahead The forthcoming stages of VIVELAB-EXO will include: Refinement of digital twin models, drawing upon broader datasets and diverse industrial scenarios. Validation in real-world industrial environments, beyond the laboratory. Development of intuitive dashboards and interfaces to guide ergonomic decision-making. Adaptability across contexts, ensuring applicability to varied exoskeleton types and work settings. Long-term impact assessments, examining reductions in injuries, absenteeism, and worker fatigue. Conclusion The milestone reached at CTAG is more than a research exercise; it is a decisive step towards re-imagining how industry safeguards its workforce.  VIVELAB-EXO  epitomises the convergence of technology, ergonomics, and human-centred design, with GOGOA proudly contributing to this European endeavour. We remain steadfast in our mission: to make tomorrow’s factories safer, more efficient, and fundamentally more humane. Onwards we go!  🚀 #Innovation #Technology #Exoskeletons #Ergonomics #DigitalTwins #Industry40 #Manufacturing #PhysicalAssistance #EITManufacturing #Gogoa

QuirónSalud Bizkaia Hospital & Gogoa Mobility Robots 👉  Registration form here Robotic Neurorehabilitation Unit On  Tuesday 21st October at 6:00 pm , the  Auditorium of Quirónsalud Bizkaia Hospital  will host the  First Health and Robotic Neurorehabilitation Symposium , an exceptional event organised by the hospital’s  Robotic Neurorehabilitation Unit  in collaboration with  Gogoa Mobility Robots , Europe’s leading enterprise in exoskeletons and advanced neurorehabilitation solutions. 👉  Registration form here This landmark occasion celebrates a  double anniversary : the  first year of the Robotic Neurorehabilitation Unit at Quirónsalud Bizkaia  – the  only hospital-based unit of its kind in the Basque Country  – and the  tenth anniversary of Gogoa Mobility Robots , a Basque pioneer in the clinical application of robotic technologies for health. A showroom with live demonstrations The highlight of the symposium will be the opportunity to  witness cutting-edge technology in action  through an  interactive showroom  featuring live demonstrations of some of the most advanced devices developed and deployed by Gogoa: HANK Exoskeleton : an international benchmark in gait rehabilitation. In the live demonstration, attendees will see how patients with neurological impairment may regain the ability to walk thanks to this state-of-the-art exoskeleton. BELK Exoskeleton : a device conceived for  gait training and the enhancement of knee mobility , making it a versatile solution for exercise programmes and preventative care. Hand of Hope (HoH) Exoskeleton : an innovative system for the  rehabilitation of hand and arm mobility . This device restores functionality and creates new opportunities to recover essential movements – from grasping an object to performing precise everyday tasks. BESK Exoskeleton : a dynamic system for the  rehabilitation of upper limbs , enabling self-initiated, adjustable and safe therapies, while improving strength, coordination, and range of motion. ALPERK Vagus Nerve Modulator : a revolutionary device that  accelerates cerebral neuroplasticity , enhancing therapeutic efficacy and fostering functional recovery up to 50% faster. Balance platforms and virtual reality systems , integrating physical and cognitive training within immersive and motivating environments. This showroom will grant attendees the chance to  interact first-hand with the technology , appreciate its mechanisms, and discover how these innovations are  transforming neurorehabilitation within the hospital environment . A pioneering hospital-based unit The  Robotic Neurorehabilitation Unit at Quirónsalud Bizkaia Hospital  is the first and only hospital-based unit of its kind in the Basque Autonomous Community, making it a distinctive and pioneering resource compared with extramural initiatives. Its  unique value  lies in the combination of  cutting-edge robotic technology  with the  safety and assurance of a hospital clinical setting , where every patient benefits from: Continuous medical supervision throughout the therapies. Immediate access to diagnostic tests and hospital services. Multidisciplinary coordination with neurology, physiotherapy, rehabilitation, and traumatology. This model ensures safe, intensive, and personalised treatment for patients with stroke, acquired brain injury, spinal cord injury, neurodegenerative conditions (such as Parkinson’s disease, multiple sclerosis, ALS), as well as post-operative sequelae and traumatic injuries. Even in chronic stages or in cases where conventional therapies have reached their limit, robotic neurorehabilitation offers  new avenues of recovery , improving strength, mobility, balance, posture, and independence. Key speakers and real-life testimonies The programme will blend scientific insight with clinical expertise and personal experience: Carlos Fernández Isoird , CEO of Gogoa Mobility Robots, on the future of neurotechnology. Sara García Delgado , specialist physiotherapist in neurology and Head of the Robotic Neurorehabilitation Unit at Quirónsalud Bizkaia Hospital. Guillermo Asín Prieto , Director of R&D at Gogoa Mobility Robots. Patients and relatives , sharing their personal testimonies and journeys of recovery. Invited medical experts  (to be confirmed: neurologists, neurosurgeons, and trauma specialists). How to attend The symposium is open to patients, relatives, healthcare professionals, and anyone wishing to discover how technology is transforming neurological rehabilitation. 📅  Tuesday, 21st October – 6:00 pm 📍  Auditorium, Quirónsalud Bizkaia Hospital 🎟️  Admission free of charge 👉  Registration form here ✨ The  First Health and Robotic Neurorehabilitation Symposium  will be far more than a scientific gathering: it will be an  immersive experience , where attendees may  witness the HANK exoskeleton and other pioneering technologies in action , engage with them directly, and appreciate how the synergy between innovation, science, and hospital care is redefining the very future of neurological rehabilitation.

The  GAIA Project – Integrated management for the prevention, extinction and reforestation of forest fires (PLEC2023-010303) , funded by the  Spanish Ministry of Science, Innovation and Universities (MICIU/AEI)  and  CDTI  under the  Transmisiones 2023 Call , continues to progress with unwavering determination. This past Tuesday, a working meeting was convened at the premises of  Tekniker , bringing together the three partners engaged in  Task 2: Advanced personal protective equipment . The principal aim of this endeavour is the seamless integration of a  modular exoskeleton into the technical garments worn by firefighters , further enhanced with advanced sensors and innovative materials designed to: Mitigate  thermal stress  during firefighting operations. Enhance the  thermal protection  of the equipment. Elevate the  safety and resilience  of professionals operating in extreme environments. During the session, the consortium shared significant achievements: GOGOA  unveiled the integration of its modular exoskeleton with the  technical garments developed by FECSA . TEKNIKER  presented its latest advances in  flexible electronics printing , embedding temperature and humidity sensors directly into the fabric. The real-time monitoring afforded by these developments will provide invaluable input for  GOGOA’s Artificial Intelligence algorithms , enabling the early detection of thermal stress, facilitating informed decision-making, and offering firefighters additional safety features such as  GPS localisation  and  hazard alert signalling via LED indicators . This gathering represents a distinguished milestone in the trajectory of the project, fortifying the collaborative spirit of the consortium and underscoring our unwavering commitment to  technological innovation in the service of safety and protection in the fight against wildfires . 📷 Below, we share a selection of images from the day at Tekniker, illustrating the collective effort and shared vision of all partners involved.

By GOGOA Mobility Robots Bilbao, 23 July 2025 Yesterday, on the 22nd of July, the world observed World Brain Day —a date that pays tribute to an organ as intricate as it is indispensable. In a world where longevity is no longer the exception but increasingly the rule, one challenge stands out above all: to ensure that our minds endure as long as our bodies. Neuroplasticity: The Fine Art of Sculpting Without a Scalpel For decades, the adult brain was thought to be static—fixed in structure and capacity. Today, that notion lies firmly in the past. The brain is a living canvas, perpetually reshaped by experience. Thanks to neuroplasticity , not only do new connections emerge, but entirely new neurons can form—particularly in the hippocampus , the brain’s centre for memory and learning. Physical activity and cognitive stimulation serve as the chisels that shape this remarkable canvas. Studies show that as little as 30–40 minutes of moderate aerobic exercise, three to four times a week , can increase hippocampal volume by 1–2%, alongside noticeable improvements in memory. The Hippocampus: Memory Expanded (N+1) Far from being static, the hippocampus is dynamic and malleable. In older adults, its volume has been shown to increase by up to 2% annually, effectively counteracting age-related decline. A recent study involving individuals with mild cognitive impairment revealed that just two weekly sessions of strength training produced the following: Protection of key brain regions such as the hippocampus and precuneus. Significant gains in verbal memory. Increased neurotrophic factors such as BDNF and irisin . In some cases, partial reversal of cognitive decline. The verdict is clear: strength training is not merely for the body—it is vital for the brain . Enriched Environments: The Brain Thrives on Complexity Environments that stimulate—learning a language, altering one’s routine, playing music, or engaging in rich social interaction—are not indulgences. They are strategic interventions in brain health. In humans, those who lead intellectually active lives retain cognitive activation patterns similar to much younger adults. This phenomenon, known as cognitive reserve , supports both neurogenesis and long-term mental agility. Synergistic Strategies: Body + Mind = Unstoppable Brain The true magic lies in synergy. Combining physical training, cognitive stimulation, nutrition and restorative rest yields exponential benefits. This is the gold standard: Aerobic exercise (3–4 times weekly, 40 minutes): Increases hippocampal volume, boosts BDNF levels, improves memory. Strength training (2 times weekly): Preserves white matter, enhances executive function. Enrichment activities (reading, languages, the arts): Stimulate neural networks and consolidate learning. Sleep and stress management : Regulate cortisol, enable glymphatic cleansing, stabilise emotional tone. MIND diet : Rich in greens, berries, omega-3s; low in processed foods—offers protection against Alzheimer’s. Neurodegeneration Prevention: An Investment in Your Future Cognitive decline is not an inevitable sentence. These strategies can reduce the risk of Alzheimer’s and related conditions by over 30%, while significantly enhancing quality of life—starting today . Think of cognitive reserve as a savings account: the more you deposit, the greater your brain’s resilience to life’s challenges. GOGOA’s Weekly Plan: Build a Smarter Brain Monday, Wednesday, Friday 40 minutes of aerobic exercise (walk, cycle, swim) 10 minutes of mindful breathing or meditation Tuesday, Thursday Strength training (weights, resistance bands or bodyweight) 15 minutes of cognitive stimulation (language learning, memory games, focused reading) Weekend Long walk plus meaningful conversation Creative time: music, writing, art, or reading for pleasure Daily essentials 7–9 hours of sleep Anti-inflammatory, brain-focused nutrition (MIND diet) Avoid screens before bedtime Maintain strong, real-life social bonds Conclusion: The Brain Does Not Take Care of Itself World Brain Day must not be a fleeting occasion—it is a call to action. Ageing is natural; cognitive decline need not be. With consistent habits, we can not only mitigate it, but in some cases, reverse it. At GOGOA, we combine cutting-edge technology with neuroscience to reimagine human potential. Yet nothing replaces the power of a trained mind, a moving body, and a resolute will to preserve that which is most precious: our identity. So—what will you do for your brain today?

REHABLA: Pioneering Speech Rehabilitation Technology in Basque and Spanish At GOGOA, we are taking yet another step towards the transformation of neurorehabilitation by seamlessly integrating cutting-edge technology , linguistic inclusivity , and expert remote supervision . We are proud to unveil REHABLA , a groundbreaking product development initiative that will allow us to bring to market the very first online speech rehabilitation platform available in both Spanish and Basque , meticulously designed for individualised use under the remote guidance of certified speech and language therapists . A New Horizon in Digital Speech Therapy REHABLA is conceived with a clear and ambitious purpose: to attain Technology Readiness Level 9 (TRL9) by developing a fully operational medical device , prepared for commercial deployment and CE certification as a Class I medical device under the Spanish Agency of Medicines and Medical Devices (AEMPS). Throughout this endeavour, the project will include: The refinement and optimisation of the existing platform. The incorporation of new features tailored to the real-world needs of patients and speech therapists. Comprehensive preparation for market launch. The drafting and formalisation of all necessary technical documentation for certification and clinical rollout. Once completed, REHABLA will be seamlessly integrated into our clinical network and specialised robotic neurorehabilitation units , enriching our therapeutic ecosystem with a multilingual solution for speech disorders . A Technology in Service of Our Clinics The successful completion of this initiative will see REHABLA become an integral part of our advanced rehabilitation services , broadening our portfolio of digital therapies and further cementing our commitment to delivering comprehensive, inclusive and evidence-based medical care . This development fortifies our standing as pioneers in advanced healthcare technology and paves the way for a more accessible, effective and human-centred approach to speech therapy . We remain steadfast in our mission: bringing the rehabilitation of tomorrow into the hands of patients today . Supported by the FAST TRACK INNOBIDEAK Programme This initiative is proudly supported by the FAST TRACK INNOBIDEAK LAGUNTZA PROGRAMA – FAST TRACK INNOBIDEAK Support Scheme , under grant QB-2024/00243 , which promotes the development and industrialisation of high-value innovation projects across the Basque Country.